Trophos Articles
Actelion pulls out of Trophos option
13 December 2011
Actelion buys option to acquire privately-held Trophos; posts strong 2nd-qtr 2010 results
20 July 2010
Showing 1-2 of 2 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
